CFO4Life Group’s American Express AXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$935K Sell
3,093
-26
-0.8% -$8.72K 0.14% 73
2025
Q4
$1.15M Sell
3,119
-166
-5% -$59.4K 0.16% 69
2025
Q3
$1.09M Buy
3,285
+38
+1% +$12.1K 0.16% 70
2025
Q2
$1.04M Buy
3,247
+98
+3% +$27.6K 0.16% 71
2025
Q1
$847K Sell
3,149
-261
-8% -$77.1K 0.14% 81
2024
Q4
$1.01M Buy
3,410
+39
+1% +$11.2K 0.18% 64
2024
Q3
$914K Sell
3,371
-283
-8% -$70.5K 0.16% 75
2024
Q2
$846K Buy
+3,654
New +$846K 0.16% 74
2023
Q4
Sell
-4,262
Closed -$636K 187
2023
Q3
$636K Sell
4,262
-105
-2% -$17.2K 0.15% 83
2023
Q2
$761K Sell
4,367
-27
-0.6% -$4.36K 0.16% 70
2023
Q1
$725K Sell
4,394
-32
-0.7% -$5.31K 0.16% 67
2022
Q4
$654K Buy
+4,426
New +$656K 0.14% 87

Other funds holding AXP

CFO4Life Group's AXP Position: Q1 2026 in Review

CFO4Life Group reduced its American Express (AXP) stake by 0.83% in Q1 2026, selling an estimated $8.72K and leaving 3,093 shares worth $935K. The position accounts for 0.14% of the portfolio, ranked #73.

CFO4Life Group first reported a position in AXP in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.15M in Q4 2025. 2,888 funds tracked by Wall St. Rank hold AXP as of Q1 2026.

  • CFO4Life Group held 3,093 shares of American Express worth $935K as of Q1 2026.
  • CFO4Life Group sold 26 American Express shares in Q1 2026, an estimated $8.72K.
  • American Express made up 0.14% of CFO4Life Group's portfolio in Q1 2026, its #73 holding.
  • CFO4Life Group first reported a position in American Express in Q4 2022 and has held it in 12 quarters since.
  • CFO4Life Group's American Express position peaked at $1.15M in Q4 2025.
  • 2,888 funds tracked by Wall St. Rank held American Express as of Q1 2026.

Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.